Drugs / Combined immune adjuvants and radiation
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03392545 | Apr 2018 → Apr 2020 | brain stem glioma, glioblastoma | Beijing Tiantan Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Combined immune adjuvants and radiation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03392545 ↗ |
| Route | Other | “poly I:C or CAR-T or TCR-T intratumorally” NCT03392545 ↗ |